CoChat

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion

Open access
Sivaprasad, Sobha, Oyetunde, Sesan · 2016 · Clinical Ophthalmology

The DOI matches its Crossref record; 32 of the 35 references it cites were found in a registry or an index.

Abstract

PURPOSE: An important factor in the choice of therapy is the impact it has on the patient's quality of life. This survey aimed to understand treatment burden, treatment-related anxiety and worry, and practical issues such as appointment attendance and work absence in patients receiving injection therapy for diabetic macular edema (DME) or retinal vein occlusion (RVO). PATIENTS AND METHODS: A European sample of 131 retinal patients completed a detailed questionnaire to elucidate the impact of injection therapy on individuals with DME or RVO. RESULTS: RVO and DME greatly impact a patient's quality of life. An intensive injection regimen and the requirements for multiple hospital visits place a large practical burden on the patient. Each intravitreal injection appointment (including travel time) was reported to take an average of 4.5 hours, with a total appointment burden over 6 months of 13.5 hours and 20 hours for RVO and DME patients, respectively. This creates a significant burden on patient time and may make appointment attendance difficult. Indeed, 53% of working patients needed to take at least 1 day off work per appointment and 71% of patients required a carer's assistance at the time of the injection appointment, ~6.3 hours per injection. In addition to practical issues, three-quarters of patients reported experiencing anxiety about their most recent injection treatment, with 54% of patients reporting that they were anxious for at least 2 days prior to the injection. Patients' most desired improvement to their treatment regimen was to have fewer injections and to require fewer appointments, to achieve the same visual results. CONCLUSION: Patients' quality of life is clearly very affected by having to manage an intensive intravitreal injection regimen, with a considerable treatment burden having a large negative effect. Reducing the appointment burden to achieve the same visual outcomes and the provision of additional support for patients to attend appointments would greatly benefit those receiving intravitreal injection therapies for DME and RVO.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/opth.s100168

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The impact of chronic conditions on patient’s quality of life. Abbreviations: DME, diabetic macular edema; RVO, retinal vein occlusion.
Figure 1 The impact of chronic conditions on patient’s quality of life. Abbreviations: DME, diabetic macular edema; RVO, retinal vein occlusion.CC BY-NC · PubMed Central
Figure 2 Appointments for patients with DME every 6 months. Notes: (A) Appointments attended by all patients with DME every 6 months. (B) Appointment calendar for an average DME patient every 6 months. It includes all appointments held by ≥50% of patients. The average number of times a patient has seen a given health care professional in a 6-month period has been rounded up or down to the nearest whole number. Abbreviations: DME, diabetic macular edema; EU, European Union; HCP, health care provider; min, minutes; GP, general practitioner.
Figure 2 Appointments for patients with DME every 6 months. Notes: (A) Appointments attended by all patients with DME every 6 months. (B) Appointment calendar for an average DME patient every 6 months. It includes all appointments held by ≥50% of patients. The average number of times a patient has seen a given health care professional in a 6-month period has been rounded up or down to the nearest whole number. Abbreviations: DME, diabetic macular edema; EU, European Union; HCP, health care provider; min, minutes; GP, general practitioner.CC BY-NC · PubMed Central
Figure 3 Impact of injection anxiety on patients. Notes: (A) Number of days patients reported feeling anxious prior to latest intravitreal injection. (B) How anxiety prior to latest intravitreal injection manifested in patients.
Figure 3 Impact of injection anxiety on patients. Notes: (A) Number of days patients reported feeling anxious prior to latest intravitreal injection. (B) How anxiety prior to latest intravitreal injection manifested in patients.CC BY-NC · PubMed Central
Figure 4 Desired improvements to the injection treatment regimen.
Figure 4 Desired improvements to the injection treatment regimen.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 1

  1. [13]Weinberg DV Seddon JM Venous occlusive diseases of the retina Albert DM Jakobiec FA Principles and Practice of Ophthalmology 2 Philadelphia W.B. Saunders Company 1994 735 746

Cited by

Items 101–134 of 134

Metadata

Authors
Sivaprasad, S., & Oyetunde, S.
Affiliations
  • NIHR Moorfields Biomedical Research Centre (GB)
  • Allergan (United Kingdom) (GB)
Corresponding author
Sivaprasad, Sobha
Venue
Clinical Ophthalmology
Published
2016-05
Volume
10
Pages
939
ISSN
  • 1177-5467 (ISSN-L)
  • 1177-5483
OpenAlex
W2394715476
Cited by
134
References
35
Citations by year
2026: 15 · 2025: 26 · 2024: 15 · 2023: 13 · 2022: 10 · 2021: 14 · 2020: 16 · 2019: 6 · 2018: 10 · 2017: 9
FWCI
8.86
Type
journal article
Language
en
Open access
Locations
  • Clinical ophthalmology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
Keywords
diabetic macular edema, retinal vein occlusion, intravitreal injection, treatment burden, quality of life, treatment-related anxiety, absenteeism, appointment attendance, caregiver support, patient preferences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.